Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0596263
Disease: Carcinogenesis
Carcinogenesis
0.080 Biomarker phenotype BEFREE DNA methylation levels of TSGs were significantly augmented by smoking, alcohol use, and betel quid chewing, indicating the fact that frequent exposure to risk factors may drive oral and oropharyngeal carcinogenesis through TSG promoter hypermethylation. 31013839 2019
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.070 Biomarker group BEFREE The TSDN revealed links between TSGs and 22 different human disorders including cancer and indicated disease-disease associations. 30945018 2019
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.040 Biomarker group BEFREE The TSDN revealed links between TSGs and 22 different human disorders including cancer and indicated disease-disease associations. 30945018 2019
CUI: C0030193
Disease: Pain
Pain
0.010 Biomarker phenotype BEFREE Pain values (according to the NRS) 1 week after the procedure were significantly lower, and the effect duration was significantly longer, after TSG PRF than after CSC PRF.TSG PRF is a more effective procedure than CSC PRF for managing chronic upper-extremity CRPS. 30702594 2019
CUI: C0458219
Disease: Complex Regional Pain Syndromes
Complex Regional Pain Syndromes
0.010 Biomarker disease BEFREE Pain values (according to the NRS) 1 week after the procedure were significantly lower, and the effect duration was significantly longer, after TSG PRF than after CSC PRF.TSG PRF is a more effective procedure than CSC PRF for managing chronic upper-extremity CRPS. 30702594 2019
CUI: C0553694
Disease: Oropharyngeal disorders
Oropharyngeal disorders
0.010 Biomarker group BEFREE DNA methylation levels of TSGs were significantly augmented by smoking, alcohol use, and betel quid chewing, indicating the fact that frequent exposure to risk factors may drive oral and oropharyngeal carcinogenesis through TSG promoter hypermethylation. 31013839 2019
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.100 PosttranslationalModification group BEFREE It has increasingly been considered crucial the understanding of DNA methylation of Tumor Suppressor Gene (TSG) promoters, such as that of retinoblastoma 1 gene (RB1), and its role during carcinogenesis. 29468541 2018
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.100 Biomarker group BEFREE In conclusion, all of our findings revealed that TWSG1 maybe serves as a tumor suppressor gene in gastric cancer and potential biomarker or therapeutic target for the diagnosis and treatment of gastric cancer. 29756996 2018
CUI: C0596263
Disease: Carcinogenesis
Carcinogenesis
0.080 Biomarker phenotype BEFREE It has increasingly been considered crucial the understanding of DNA methylation of Tumor Suppressor Gene (TSG) promoters, such as that of retinoblastoma 1 gene (RB1), and its role during carcinogenesis. 29468541 2018
CUI: C1269955
Disease: Tumor Cell Invasion
Tumor Cell Invasion
0.020 PosttranslationalModification phenotype BEFREE Our data support a possible role of DNMT1 and DNMT3A in TSG promoter methylation leading to pituitary adenoma invasion and suggest that inhibition of DNMTs has the potential to become a new therapeutic approach for invasive pituitary adenoma. 30002361 2018
CUI: C0000768
Disease: Congenital Abnormality
Congenital Abnormality
0.010 Biomarker group BEFREE In conclusion, we found that in endothelial cells, BMPER and TWSG1 are necessary for regular Notch signaling activity and in zebrafish embryos BMPER and TWSG1 preserve arteriovenous specification to prevent malformations. 29473997 2018
CUI: C0002395
Disease: Alzheimer's Disease
Alzheimer's Disease
0.010 Biomarker disease BEFREE TSG performs prophylactic and therapeutic activities against Alzheimer's disease, Parkinson's disease, and cerebral ischemia/reperfusion injury. 30524653 2018
CUI: C0024623
Disease: Malignant neoplasm of stomach
Malignant neoplasm of stomach
0.010 Biomarker disease BEFREE In conclusion, all of our findings revealed that TWSG1 maybe serves as a tumor suppressor gene in gastric cancer and potential biomarker or therapeutic target for the diagnosis and treatment of gastric cancer. 29756996 2018
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma
0.010 Biomarker disease BEFREE In conclusion, all of our findings revealed that TWSG1 maybe serves as a tumor suppressor gene in gastric cancer and potential biomarker or therapeutic target for the diagnosis and treatment of gastric cancer. 29756996 2018
CUI: C2960725
Disease: Invasive pituitary adenoma
Invasive pituitary adenoma
0.010 PosttranslationalModification disease BEFREE Our data support a possible role of DNMT1 and DNMT3A in TSG promoter methylation leading to pituitary adenoma invasion and suggest that inhibition of DNMTs has the potential to become a new therapeutic approach for invasive pituitary adenoma. 30002361 2018
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.100 Biomarker group BEFREE Matrigel assays demonstrated the effect of tumor cell-derived TWSG1 on endothelial cell function. 28928871 2017
CUI: C0596263
Disease: Carcinogenesis
Carcinogenesis
0.080 GeneticVariation phenotype BEFREE Our data reveal that TSG gene PHF2 harbors mutational ITH as well as the frameshift mutations in CRC and GC with MSI-H. Based on this, it is suggested that frameshift mutations of PHF2 may play a role in tumorigenesis through its TSG inactivation in CRC and GC. 27744626 2017
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.030 Biomarker disease BEFREE Our findings suggested that TSG may serve as a source to isolate anti-HCC therapeutic ingredients. 29234432 2017
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.020 Biomarker phenotype BEFREE However, the functions and mechanisms of TWSG1 in papillary thyroid cancer (PTC) metastasis have not been reported. 28928871 2017
CUI: C1269955
Disease: Tumor Cell Invasion
Tumor Cell Invasion
0.020 AlteredExpression phenotype BEFREE In conclusion, TWSG1 was highly expressed in metastasized PTC; tumor growth, migration and invasion were dependent on TWSG1, and it may be a new diagnostic and therapeutic target for PTC. 28928871 2017
CUI: C0009402
Disease: Colorectal Carcinoma
Colorectal Carcinoma
0.010 GeneticVariation disease BEFREE Our data reveal that TSG gene PHF2 harbors mutational ITH as well as the frameshift mutations in CRC and GC with MSI-H. Based on this, it is suggested that frameshift mutations of PHF2 may play a role in tumorigenesis through its TSG inactivation in CRC and GC. 27744626 2017
Secondary malignant neoplasm of lung
0.010 Biomarker disease BEFREE Cabozantinib treatment caused striking tumor regression and inhibited lung metastasis in TSG-RCC-030. 27715452 2017
CUI: C0238463
Disease: Papillary thyroid carcinoma
Papillary thyroid carcinoma
0.010 AlteredExpression disease BEFREE Our results showed that TWSG1 expression was significantly enhanced in PTC with LNM compared to that in PTC without LNM. 28928871 2017
Secondary malignant neoplasm of lymph node
0.010 AlteredExpression disease BEFREE Our results showed that TWSG1 expression was significantly enhanced in PTC with LNM compared to that in PTC without LNM. 28928871 2017
CUI: C1306837
Disease: Papillary Renal Cell Carcinoma
Papillary Renal Cell Carcinoma
0.010 Biomarker disease BEFREE Precision-cut, thin tissue slices from a pRCC specimen obtained by nephrectomy were implanted under the renal capsule of RAG2<sup>-/-</sup>γC<sup>-/-</sup> mice to establish first generation TSG-RCC-030. 27715452 2017